Impact of malignancy on laboratory parameters and survival in patients with pulmonary embolism
Anatolian Current Medical Journal · 16.07.2026 · 8 (4) · 625-630
DOI: 10.38053/acmj.1938145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anatolian Current Medical Journal, online erschienen am 16.07.2026. Verfasst von Selda Günaydın und 1 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Aims
Pulmonary embolism (PE) is a life-threatening disease associated with significant morbidity and mortality, particularly in presence of malignancy. This study aimed to compare laboratory parameters with short-term and long-term mortality outcomes between malignant and non-malignant PE patients.
Methods
In this retrospective study, 131 patients diagnosed with acute PE by computed tomography pulmonary angiography were included. Participants were divided into malignant (n=47) and non-malignant (n=84) groups. Demographic characteristics, laboratory parameters, and clinical findings were analyzed. The primary outcomes were 30-day and 365-day mortality, while secondary outcomes included 90-day and 180-day mortality.
Results
Patients in the malignant group were younger and more frequently male (p
Zitieren
APA
Günaydın, S., & Aksoy, H. B. (2026). Impact of malignancy on laboratory parameters and survival in patients with pulmonary embolism. Anatolian Current Medical Journal, 8(4), 625-630. https://doi.org/10.38053/acmj.1938145
Vancouver
Günaydın S, Aksoy HB. Impact of malignancy on laboratory parameters and survival in patients with pulmonary embolism. Anatolian Current Medical Journal. 2026;8(4):625-630. doi:10.38053/acmj.1938145
BibTeX
@article{Gnaydn2026,
author = {Günaydın, Selda and Aksoy, Hayriye Bektaş},
title = {Impact of malignancy on laboratory parameters and survival in patients with pulmonary embolism},
journal = {Anatolian Current Medical Journal},
year = {2026},
volume = {8},
number = {4},
pages = {625--630},
doi = {10.38053/acmj.1938145}
}
EUVIMED